Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-539,437
-615,061
515,837
528,584
-298,665
Depreciation & amortisation
18,330
19,451
6,783
5,811
5,442
Deferred income taxes
-
-1,063
-15,186
15,186
-52
Stock-based compensation
109,592
111,316
102,082
83,784
27,600
Change in working capital
-397,463
-304,591
665,367
-628,394
29,522
Accounts receivable
-3,059
-565
770,038
-773,079
0
Accounts payable
-5,097
732
797
-171
-790
Other working capital
-778,971
-800,358
1,595,247
-69,406
-197,490
Other non-cash items
6,025
-27,989
277,230
85,489
26,036
Net cash provided by operating activities
-762,393
-778,785
1,663,253
-47,589
-190,941
Cash flows from investing activities
Investments in property, plant and equipment
-16,578
-21,573
-68,006
-21,817
-6,549
Purchases of investments
-2,194,615
-2,016,189
-1,476,965
-420,240
-403,841
Sales/maturities of investments
2,305,630
2,202,391
351,510
301,243
400,348
Other investing activities
-
-
-
-
180
Net cash used for investing activities
94,970
164,629
-1,193,461
-140,814
-9,862
Cash flows from financing activities
Debt repayment
-290
-287
-260
-259
-250
Common stock issued
-
0
28,462
85,213
529,913
Common stock repurchased
-
-
-
0
0
Other financing activities
-
-
-1,197
-
-4,248
Net cash used provided by (used for) financing activities
5,288
7,480
34,761
100,331
529,474
Net change in cash
-662,135
-606,676
504,553
-88,072
328,671
Cash at beginning of period
842,609
867,968
363,415
451,487
122,816
Cash at end of period
180,474
261,292
867,968
363,415
451,487
Free cash flow
Operating cash flow
-762,393
-778,785
1,663,253
-47,589
-190,941
Capital expenditure
-16,578
-21,573
-68,006
-21,817
-6,549
Free cash flow
-778,971
-800,358
1,595,247
-69,406
-197,490
© 2024 Yahoo. All rights reserved.